ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Non-Adhesive Liquid Embolic Agents Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-29P19623
Home | Market Reports | Health| Pharmacy
Global Non Adhesive Liquid Embolic Agents Market Outlook In Depth Analysis Forecast to 2031
BUY CHAPTERS

Global Non-Adhesive Liquid Embolic Agents Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-29P19623
Report
October 2025
Pages:145
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Medtronic Inc
Balt Group
Johnson & Johnson
Meril Life
BlackSwan Vascular
Success Bio-Tech

Non-Adhesive Liquid Embolic Agents Market Size

The global Non-Adhesive Liquid Embolic Agents market is projected to grow from US$ 143 million in 2024 to US$ 237 million by 2031, at a CAGR of 7.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Non-Adhesive Liquid Embolic Agents Market

Non-Adhesive Liquid Embolic Agents Market

Non-adhesive liquid embolic agents are a type of medical substance used in interventional procedures, particularly in endovascular embolization treatments, to block blood vessels. Unlike traditional adhesive embolic agents, which rely on chemical bonding to vessel walls, non-adhesive liquid embolics do not adhere to tissue but instead occlude blood flow by physically plugging the vessel lumen. These agents are typically delivered through a catheter and are designed to solidify or gel after being injected, forming a stable mass that prevents further blood flow. They are often used for treating conditions like arteriovenous malformations (AVMs), tumors, or aneurysms, where precise occlusion of abnormal blood vessels is required.
From a downstream perspective, Brain Arterio-Venous Malformations (bAVM) accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Non-Adhesive Liquid Embolic Agents leading manufacturers including Medtronic, Balt Group, Johnson & Johnson, Meril Life, BlackSwan Vascular, Success Bio-Tech, etc., dominate supply; the top five capture approximately % of global revenue, with Medtronic leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Non-Adhesive Liquid Embolic Agents market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Non-Adhesive Liquid Embolic Agents Market Report

Report Metric Details
Report Name Non-Adhesive Liquid Embolic Agents Market
Accounted market size in 2024 US$ 143 million
Forecasted market size in 2031 US$ 237 million
CAGR 7.6%
Base Year 2024
Forecasted years 2025 - 2031
Segment by Type
  • EVOH-Based
  • Diluted Cyanoacrylate
  • Others
Segment by Application
  • Brain Arterio-Venous Malformations (bAVM)
  • Tumor Embolization
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Medtronic, Balt Group, Johnson & Johnson, Meril Life, BlackSwan Vascular, Success Bio-Tech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Non-Adhesive Liquid Embolic Agents study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Non-Adhesive Liquid Embolic Agents Market growing?

Ans: The Non-Adhesive Liquid Embolic Agents Market witnessing a CAGR of 7.6% during the forecast period 2025-2031.

What is the Non-Adhesive Liquid Embolic Agents Market size in 2031?

Ans: The Non-Adhesive Liquid Embolic Agents Market size in 2031 will be US$ 237 million.

Who are the main players in the Non-Adhesive Liquid Embolic Agents Market report?

Ans: The main players in the Non-Adhesive Liquid Embolic Agents Market are Medtronic, Balt Group, Johnson & Johnson, Meril Life, BlackSwan Vascular, Success Bio-Tech

What are the Application segmentation covered in the Non-Adhesive Liquid Embolic Agents Market report?

Ans: The Applications covered in the Non-Adhesive Liquid Embolic Agents Market report are Brain Arterio-Venous Malformations (bAVM), Tumor Embolization, Others

What are the Type segmentation covered in the Non-Adhesive Liquid Embolic Agents Market report?

Ans: The Types covered in the Non-Adhesive Liquid Embolic Agents Market report are EVOH-Based, Diluted Cyanoacrylate, Others

1 Study Coverage
1.1 Introduction to Non-Adhesive Liquid Embolic Agents: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Non-Adhesive Liquid Embolic Agents Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 EVOH-Based
1.2.3 Diluted Cyanoacrylate
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Non-Adhesive Liquid Embolic Agents Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Brain Arterio-Venous Malformations (bAVM)
1.3.3 Tumor Embolization
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Non-Adhesive Liquid Embolic Agents Revenue Estimates and Forecasts 2020-2031
2.2 Global Non-Adhesive Liquid Embolic Agents Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Non-Adhesive Liquid Embolic Agents Sales Estimates and Forecasts 2020-2031
2.4 Global Non-Adhesive Liquid Embolic Agents Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Non-Adhesive Liquid Embolic Agents Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Non-Adhesive Liquid Embolic Agents Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 EVOH-Based Market Size by Manufacturers
3.5.2 Diluted Cyanoacrylate Market Size by Manufacturers
3.5.3 Others Market Size by Manufacturers
3.6 Global Non-Adhesive Liquid Embolic Agents Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Non-Adhesive Liquid Embolic Agents Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Non-Adhesive Liquid Embolic Agents Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Non-Adhesive Liquid Embolic Agents Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Non-Adhesive Liquid Embolic Agents Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Non-Adhesive Liquid Embolic Agents Sales and Revenue by Type (2020-2031)
6.4 North America Non-Adhesive Liquid Embolic Agents Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Non-Adhesive Liquid Embolic Agents Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Non-Adhesive Liquid Embolic Agents Sales and Revenue by Type (2020-2031)
7.4 Europe Non-Adhesive Liquid Embolic Agents Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Non-Adhesive Liquid Embolic Agents Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Non-Adhesive Liquid Embolic Agents Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Non-Adhesive Liquid Embolic Agents Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Non-Adhesive Liquid Embolic Agents Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Non-Adhesive Liquid Embolic Agents Sales and Revenue by Type (2020-2031)
9.4 Central and South America Non-Adhesive Liquid Embolic Agents Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Non-Adhesive Liquid Embolic Agents Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Non-Adhesive Liquid Embolic Agents Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Non-Adhesive Liquid Embolic Agents Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Non-Adhesive Liquid Embolic Agents Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Non-Adhesive Liquid Embolic Agents Product Models, Descriptions and Specifications
11.1.4 Medtronic Non-Adhesive Liquid Embolic Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Medtronic Non-Adhesive Liquid Embolic Agents Sales by Product in 2024
11.1.6 Medtronic Non-Adhesive Liquid Embolic Agents Sales by Application in 2024
11.1.7 Medtronic Non-Adhesive Liquid Embolic Agents Sales by Geographic Area in 2024
11.1.8 Medtronic Non-Adhesive Liquid Embolic Agents SWOT Analysis
11.1.9 Medtronic Recent Developments
11.2 Balt Group
11.2.1 Balt Group Corporation Information
11.2.2 Balt Group Business Overview
11.2.3 Balt Group Non-Adhesive Liquid Embolic Agents Product Models, Descriptions and Specifications
11.2.4 Balt Group Non-Adhesive Liquid Embolic Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Balt Group Non-Adhesive Liquid Embolic Agents Sales by Product in 2024
11.2.6 Balt Group Non-Adhesive Liquid Embolic Agents Sales by Application in 2024
11.2.7 Balt Group Non-Adhesive Liquid Embolic Agents Sales by Geographic Area in 2024
11.2.8 Balt Group Non-Adhesive Liquid Embolic Agents SWOT Analysis
11.2.9 Balt Group Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Non-Adhesive Liquid Embolic Agents Product Models, Descriptions and Specifications
11.3.4 Johnson & Johnson Non-Adhesive Liquid Embolic Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Johnson & Johnson Non-Adhesive Liquid Embolic Agents Sales by Product in 2024
11.3.6 Johnson & Johnson Non-Adhesive Liquid Embolic Agents Sales by Application in 2024
11.3.7 Johnson & Johnson Non-Adhesive Liquid Embolic Agents Sales by Geographic Area in 2024
11.3.8 Johnson & Johnson Non-Adhesive Liquid Embolic Agents SWOT Analysis
11.3.9 Johnson & Johnson Recent Developments
11.4 Meril Life
11.4.1 Meril Life Corporation Information
11.4.2 Meril Life Business Overview
11.4.3 Meril Life Non-Adhesive Liquid Embolic Agents Product Models, Descriptions and Specifications
11.4.4 Meril Life Non-Adhesive Liquid Embolic Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Meril Life Non-Adhesive Liquid Embolic Agents Sales by Product in 2024
11.4.6 Meril Life Non-Adhesive Liquid Embolic Agents Sales by Application in 2024
11.4.7 Meril Life Non-Adhesive Liquid Embolic Agents Sales by Geographic Area in 2024
11.4.8 Meril Life Non-Adhesive Liquid Embolic Agents SWOT Analysis
11.4.9 Meril Life Recent Developments
11.5 BlackSwan Vascular
11.5.1 BlackSwan Vascular Corporation Information
11.5.2 BlackSwan Vascular Business Overview
11.5.3 BlackSwan Vascular Non-Adhesive Liquid Embolic Agents Product Models, Descriptions and Specifications
11.5.4 BlackSwan Vascular Non-Adhesive Liquid Embolic Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 BlackSwan Vascular Non-Adhesive Liquid Embolic Agents Sales by Product in 2024
11.5.6 BlackSwan Vascular Non-Adhesive Liquid Embolic Agents Sales by Application in 2024
11.5.7 BlackSwan Vascular Non-Adhesive Liquid Embolic Agents Sales by Geographic Area in 2024
11.5.8 BlackSwan Vascular Non-Adhesive Liquid Embolic Agents SWOT Analysis
11.5.9 BlackSwan Vascular Recent Developments
11.6 Success Bio-Tech
11.6.1 Success Bio-Tech Corporation Information
11.6.2 Success Bio-Tech Business Overview
11.6.3 Success Bio-Tech Non-Adhesive Liquid Embolic Agents Product Models, Descriptions and Specifications
11.6.4 Success Bio-Tech Non-Adhesive Liquid Embolic Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Success Bio-Tech Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Non-Adhesive Liquid Embolic Agents Industry Chain
12.2 Non-Adhesive Liquid Embolic Agents Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Non-Adhesive Liquid Embolic Agents Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Non-Adhesive Liquid Embolic Agents Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Non-Adhesive Liquid Embolic Agents Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Non-Adhesive Liquid Embolic Agents Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Medtronic Inc
Balt Group
Johnson & Johnson
Meril Life
BlackSwan Vascular
Success Bio-Tech
List of Tables
 Table 1. Global Non-Adhesive Liquid Embolic Agents Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Non-Adhesive Liquid Embolic Agents Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Non-Adhesive Liquid Embolic Agents Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Non-Adhesive Liquid Embolic Agents Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Non-Adhesive Liquid Embolic Agents Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Non-Adhesive Liquid Embolic Agents Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Dose)
 Table 7. Global Non-Adhesive Liquid Embolic Agents Sales by Region (2020-2025) & (K Dose)
 Table 8. Global Non-Adhesive Liquid Embolic Agents Sales by Region (2026-2031) & (K Dose)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Non-Adhesive Liquid Embolic Agents Sales by Manufacturers (2020-2025) & (K Dose)
 Table 11. Global Non-Adhesive Liquid Embolic Agents Sales Share by Manufacturers (2020-2025)
 Table 12. Global Non-Adhesive Liquid Embolic Agents Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Non-Adhesive Liquid Embolic Agents by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Adhesive Liquid Embolic Agents as of 2024)
 Table 16. Global Non-Adhesive Liquid Embolic Agents Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Non-Adhesive Liquid Embolic Agents Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Dose)
 Table 18. Key Manufacturers Non-Adhesive Liquid Embolic Agents Manufacturing Base and Headquarters
 Table 19. Global Non-Adhesive Liquid Embolic Agents Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Non-Adhesive Liquid Embolic Agents Sales by Type (2020-2025) & (K Dose)
 Table 23. Global Non-Adhesive Liquid Embolic Agents Sales by Type (2026-2031) & (K Dose)
 Table 24. Global Non-Adhesive Liquid Embolic Agents Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Non-Adhesive Liquid Embolic Agents Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Non-Adhesive Liquid Embolic Agents ASP by Type (2020-2031) & (US$/Dose)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Non-Adhesive Liquid Embolic Agents Sales by Application (2020-2025) & (K Dose)
 Table 29. Global Non-Adhesive Liquid Embolic Agents Sales by Application (2026-2031) & (K Dose)
 Table 30. Non-Adhesive Liquid Embolic Agents High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Non-Adhesive Liquid Embolic Agents Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Non-Adhesive Liquid Embolic Agents Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Non-Adhesive Liquid Embolic Agents ASP by Application (2020-2031) & (US$/Dose)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Non-Adhesive Liquid Embolic Agents Growth Accelerators and Market Barriers
 Table 37. North America Non-Adhesive Liquid Embolic Agents Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Non-Adhesive Liquid Embolic Agents Sales (K Dose) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Non-Adhesive Liquid Embolic Agents Growth Accelerators and Market Barriers
 Table 40. Europe Non-Adhesive Liquid Embolic Agents Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Non-Adhesive Liquid Embolic Agents Sales (K Dose) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Non-Adhesive Liquid Embolic Agents Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Non-Adhesive Liquid Embolic Agents Sales (K Dose) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Non-Adhesive Liquid Embolic Agents Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Non-Adhesive Liquid Embolic Agents Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Non-Adhesive Liquid Embolic Agents Investment Opportunities and Key Challenges
 Table 47. Central and South America Non-Adhesive Liquid Embolic Agents Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Non-Adhesive Liquid Embolic Agents Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Non-Adhesive Liquid Embolic Agents Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Medtronic Corporation Information
 Table 51. Medtronic Description and Major Businesses
 Table 52. Medtronic Product Models, Descriptions and Specifications
 Table 53. Medtronic Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 54. Medtronic Sales Value Proportion by Product in 2024
 Table 55. Medtronic Sales Value Proportion by Application in 2024
 Table 56. Medtronic Sales Value Proportion by Geographic Area in 2024
 Table 57. Medtronic Non-Adhesive Liquid Embolic Agents SWOT Analysis
 Table 58. Medtronic Recent Developments
 Table 59. Balt Group Corporation Information
 Table 60. Balt Group Description and Major Businesses
 Table 61. Balt Group Product Models, Descriptions and Specifications
 Table 62. Balt Group Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 63. Balt Group Sales Value Proportion by Product in 2024
 Table 64. Balt Group Sales Value Proportion by Application in 2024
 Table 65. Balt Group Sales Value Proportion by Geographic Area in 2024
 Table 66. Balt Group Non-Adhesive Liquid Embolic Agents SWOT Analysis
 Table 67. Balt Group Recent Developments
 Table 68. Johnson & Johnson Corporation Information
 Table 69. Johnson & Johnson Description and Major Businesses
 Table 70. Johnson & Johnson Product Models, Descriptions and Specifications
 Table 71. Johnson & Johnson Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 72. Johnson & Johnson Sales Value Proportion by Product in 2024
 Table 73. Johnson & Johnson Sales Value Proportion by Application in 2024
 Table 74. Johnson & Johnson Sales Value Proportion by Geographic Area in 2024
 Table 75. Johnson & Johnson Non-Adhesive Liquid Embolic Agents SWOT Analysis
 Table 76. Johnson & Johnson Recent Developments
 Table 77. Meril Life Corporation Information
 Table 78. Meril Life Description and Major Businesses
 Table 79. Meril Life Product Models, Descriptions and Specifications
 Table 80. Meril Life Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 81. Meril Life Sales Value Proportion by Product in 2024
 Table 82. Meril Life Sales Value Proportion by Application in 2024
 Table 83. Meril Life Sales Value Proportion by Geographic Area in 2024
 Table 84. Meril Life Non-Adhesive Liquid Embolic Agents SWOT Analysis
 Table 85. Meril Life Recent Developments
 Table 86. BlackSwan Vascular Corporation Information
 Table 87. BlackSwan Vascular Description and Major Businesses
 Table 88. BlackSwan Vascular Product Models, Descriptions and Specifications
 Table 89. BlackSwan Vascular Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 90. BlackSwan Vascular Sales Value Proportion by Product in 2024
 Table 91. BlackSwan Vascular Sales Value Proportion by Application in 2024
 Table 92. BlackSwan Vascular Sales Value Proportion by Geographic Area in 2024
 Table 93. BlackSwan Vascular Non-Adhesive Liquid Embolic Agents SWOT Analysis
 Table 94. BlackSwan Vascular Recent Developments
 Table 95. Success Bio-Tech Corporation Information
 Table 96. Success Bio-Tech Description and Major Businesses
 Table 97. Success Bio-Tech Product Models, Descriptions and Specifications
 Table 98. Success Bio-Tech Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 99. Success Bio-Tech Recent Developments
 Table 100. Key Raw Materials Distribution
 Table 101. Raw Materials Key Suppliers
 Table 102. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 103. Milestones in Production Technology Evolution
 Table 104. Distributors List
 Table 105. Market Trends and Market Evolution
 Table 106. Market Drivers and Opportunities
 Table 107. Market Challenges, Risks, and Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources


List of Figures
 Figure 1. Non-Adhesive Liquid Embolic Agents Product Picture
 Figure 2. Global Non-Adhesive Liquid Embolic Agents Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. EVOH-Based Product Picture
 Figure 4. Diluted Cyanoacrylate Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global Non-Adhesive Liquid Embolic Agents Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Brain Arterio-Venous Malformations (bAVM)
 Figure 8. Tumor Embolization
 Figure 9. Others
 Figure 10. Non-Adhesive Liquid Embolic Agents Report Years Considered
 Figure 11. Global Non-Adhesive Liquid Embolic Agents Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Non-Adhesive Liquid Embolic Agents Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Non-Adhesive Liquid Embolic Agents Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Region (2020-2031)
 Figure 15. Global Non-Adhesive Liquid Embolic Agents Sales (2020-2031) & (K Dose)
 Figure 16. Global Non-Adhesive Liquid Embolic Agents Sales (CAGR) by Region (2020-2031) (K Dose)
 Figure 17. Global Non-Adhesive Liquid Embolic Agents Sales Market Share by Region (2020-2031)
 Figure 18. Top 5 and Top 10 Manufacturers Non-Adhesive Liquid Embolic Agents Sales Volume Market Share in 2024
 Figure 19. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share Ranking (2024)
 Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 21. EVOH-Based Revenue Market Share by Manufacturer in 2024
 Figure 22. Diluted Cyanoacrylate Revenue Market Share by Manufacturer in 2024
 Figure 23. Others Revenue Market Share by Manufacturer in 2024
 Figure 24. Global Non-Adhesive Liquid Embolic Agents Sales Market Share by Type (2020-2031)
 Figure 25. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Type (2020-2031)
 Figure 26. Global Non-Adhesive Liquid Embolic Agents Sales Market Share by Application (2020-2031)
 Figure 27. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Application (2020-2031)
 Figure 28. North America Non-Adhesive Liquid Embolic Agents Sales YoY (2020-2031) & (K Dose)
 Figure 29. North America Non-Adhesive Liquid Embolic Agents Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. North America Top 5 Manufacturers Non-Adhesive Liquid Embolic Agents Sales Revenue (US$ Million) in 2024
 Figure 31. North America Non-Adhesive Liquid Embolic Agents Sales Volume (K Dose) by Type (2020- 2031)
 Figure 32. North America Non-Adhesive Liquid Embolic Agents Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 33. North America Non-Adhesive Liquid Embolic Agents Sales Volume (K Dose) by Application (2020-2031)
 Figure 34. North America Non-Adhesive Liquid Embolic Agents Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 35. US Non-Adhesive Liquid Embolic Agents Revenue (2020-2031) & (US$ Million)
 Figure 36. Canada Non-Adhesive Liquid Embolic Agents Revenue (2020-2031) & (US$ Million)
 Figure 37. Mexico Non-Adhesive Liquid Embolic Agents Revenue (2020-2031) & (US$ Million)
 Figure 38. Europe Non-Adhesive Liquid Embolic Agents Sales YoY (2020-2031) & (K Dose)
 Figure 39. Europe Non-Adhesive Liquid Embolic Agents Revenue YoY (2020-2031) & (US$ Million)
 Figure 40. Europe Top 5 Manufacturers Non-Adhesive Liquid Embolic Agents Sales Revenue (US$ Million) in 2024
 Figure 41. Europe Non-Adhesive Liquid Embolic Agents Sales Volume (K Dose) by Type (2020-2031)
 Figure 42. Europe Non-Adhesive Liquid Embolic Agents Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 43. Europe Non-Adhesive Liquid Embolic Agents Sales Volume (K Dose) by Application (2020-2031)
 Figure 44. Europe Non-Adhesive Liquid Embolic Agents Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 45. Germany Non-Adhesive Liquid Embolic Agents Revenue (2020-2031) & (US$ Million)
 Figure 46. France Non-Adhesive Liquid Embolic Agents Revenue (2020-2031) & (US$ Million)
 Figure 47. U.K. Non-Adhesive Liquid Embolic Agents Revenue (2020-2031) & (US$ Million)
 Figure 48. Italy Non-Adhesive Liquid Embolic Agents Revenue (2020-2031) & (US$ Million)
 Figure 49. Russia Non-Adhesive Liquid Embolic Agents Revenue (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Non-Adhesive Liquid Embolic Agents Sales YoY (2020-2031) & (K Dose)
 Figure 51. Asia-Pacific Non-Adhesive Liquid Embolic Agents Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Asia-Pacific Top 8 Manufacturers Non-Adhesive Liquid Embolic Agents Sales Revenue (US$ Million) in 2024
 Figure 53. Asia-Pacific Non-Adhesive Liquid Embolic Agents Sales Volume (K Dose) by Type (2020- 2031)
 Figure 54. Asia-Pacific Non-Adhesive Liquid Embolic Agents Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 55. Asia-Pacific Non-Adhesive Liquid Embolic Agents Sales Volume (K Dose) by Application (2020-2031)
 Figure 56. Asia-Pacific Non-Adhesive Liquid Embolic Agents Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Indonesia Non-Adhesive Liquid Embolic Agents Revenue (2020-2031) & (US$ Million)
 Figure 58. Japan Non-Adhesive Liquid Embolic Agents Revenue (2020-2031) & (US$ Million)
 Figure 59. South Korea Non-Adhesive Liquid Embolic Agents Revenue (2020-2031) & (US$ Million)
 Figure 60. China Taiwan Non-Adhesive Liquid Embolic Agents Revenue (2020-2031) & (US$ Million)
 Figure 61. India Non-Adhesive Liquid Embolic Agents Revenue (2020-2031) & (US$ Million)
 Figure 62. Central and South America Non-Adhesive Liquid Embolic Agents Sales YoY (2020-2031) & (K Dose)
 Figure 63. Central and South America Non-Adhesive Liquid Embolic Agents Revenue YoY (2020-2031) & (US$ Million)
 Figure 64. Central and South America Top 5 Manufacturers Non-Adhesive Liquid Embolic Agents Sales Revenue (US$ Million) in 2024
 Figure 65. Central and South America Non-Adhesive Liquid Embolic Agents Sales Volume (K Dose) by Type (2021-2031)
 Figure 66. Central and South America Non-Adhesive Liquid Embolic Agents Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 67. Central and South America Non-Adhesive Liquid Embolic Agents Sales Volume (K Dose) by Application (2020-2031)
 Figure 68. Central and South America Non-Adhesive Liquid Embolic Agents Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 69. Brazil Non-Adhesive Liquid Embolic Agents Revenue (2020-2025) & (US$ Million)
 Figure 70. Argentina Non-Adhesive Liquid Embolic Agents Revenue (2020-2025) & (US$ Million)
 Figure 71. Middle East, and Africa Non-Adhesive Liquid Embolic Agents Sales YoY (2020-2031) & (K Dose)
 Figure 72. Middle East and Africa Non-Adhesive Liquid Embolic Agents Revenue YoY (2020-2031) & (US$ Million)
 Figure 73. Middle East and Africa Top 5 Manufacturers Non-Adhesive Liquid Embolic Agents Sales Revenue (US$ Million) in 2024
 Figure 74. Middle East and Africa Non-Adhesive Liquid Embolic Agents Sales Volume (K Dose) by Type (2021-2031)
 Figure 75. South America Non-Adhesive Liquid Embolic Agents Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 76. Middle East and Africa Non-Adhesive Liquid Embolic Agents Sales Volume (K Dose) by Application (2020-2031)
 Figure 77. Middle East and Africa Non-Adhesive Liquid Embolic Agents Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 78. GCC Countries Non-Adhesive Liquid Embolic Agents Revenue (2020-2025) & (US$ Million)
 Figure 79. Turkey Non-Adhesive Liquid Embolic Agents Revenue (2020-2025) & (US$ Million)
 Figure 80. Egypt Non-Adhesive Liquid Embolic Agents Revenue (2020-2025) & (US$ Million)
 Figure 81. South Africa Non-Adhesive Liquid Embolic Agents Revenue (2020-2025) & (US$ Million)
 Figure 82. Non-Adhesive Liquid Embolic Agents Industry Chain Mapping
 Figure 83. Regional Non-Adhesive Liquid Embolic Agents Manufacturing Base Distribution (%)
 Figure 84. Global Non-Adhesive Liquid Embolic Agents Production Market Share by Region (2020-2031)
 Figure 85. Non-Adhesive Liquid Embolic Agents Production Process
 Figure 86. Regional Non-Adhesive Liquid Embolic Agents Production Cost Structure
 Figure 87. Channels of Distribution (Direct Vs Distribution)
 Figure 88. Bottom-up and Top-down Approaches for This Report
 Figure 89. Data Triangulation
 Figure 90. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Prednisolone Tablets Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-20R20084
Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Global Medical Liquid Dressing Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-32I19797
Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Global Suppository Base Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-14P20017
Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Global Non-Adhesive Liquid Embolic Agents Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-29P19623
Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions